Andrew D. Dickinson, the Chief Financial Officer of Gilead Sciences, Inc. (NASDAQ:GILD), a prominent biotechnology company with a market capitalization of $113 billion and "GREAT" financial health ...

The Supreme Court will hear a challenge to Obamacare’s preventive care mandates, giving Trump a chance to reshape rules on ...

Ainara Pedroso, who lives in Cork, opened up about learning she was HIV positive, which led her to fearing she wouldn't find ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of ...

January 16, 2025 -- Today, Public Health Director Dr. Grant Colfax announced his resignation from the San Francisco Department of Public Health (SFDPH) after nearly six years.

San Francisco’s public health director, who oversaw the city’s responses to the COVID-19 pandemic and fentanyl crisis, ...

USAID remains a steadfast partner to countries across Africa. As 2024 draws to a close, we look forward to building on the progress made and helping advance development goals across the continent.

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where ...

While he was a senior house officer in Ashington, Northumberland, Mike Snow developed open tuberculosis. He had a considerable amount of time off work, including 100 days of intramuscular injections ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

The U.S. initiative to fight HIV globally, PEPFAR, is at a crossroad where it must focus on sustainable health systems and ...

During the first nine months of 2024, over 70 HIV-positive males are between 15-24 years old, while only five female cases ...